Visceral fat is one of the more dangerous types of fat. Fortunately, visceral fat can easily be treated and even be removed, and recently, a drink has proven to be able to reduce the visceral fat.
Express reports that black tea has been proven in helping reduce the visceral fat found in the abdominal cavity. Black tea is a kind of tea that has gone through many oxidation processes compared to other kinds of tea. A study was conducted regarding the benefits of this tea, with 111 people taking part. The participants had to drink three cups of black tea every day for a period of three months.
At the end of the study, the participants experienced a significant weight loss as well as a smaller waistline compared to drinking a weight loss beverage that also contains caffeine. Other researchers believe that this is because black tea is high on flavone - a kind of plant pigment with antioxidant properties.
It bears noting that black tea is also generally known by many to help in weight loss. Green tea is also popularly known to aid in overall weight loss as well, reducing the visceral fat.
Another study involved 2,280 adults in a timeframe of 14 years also found that those who consumed high-flavone food and drinks have a lower body mass index compared to those who did not. All in all, regularly drinking green and/or black tea can help promote overall weight loss.
Visceral fat is mostly caused by poor lifestyle choices, the diet being the main one. This is why a good diet and regular exercise can help get rid of the fat while shedding pounds. It is highly advised to cut down or steer clear of alcoholic beverages, sugar-sweetened drinks like sodas as well as fruit juices - however, fruit juices can still be advised due to their vitamin contents, it is all down to how much fruit juice can be consumed every day and being mindful of the sugar content in the juices.
As far as diets are concerned, one of the most effective diets in getting rid of visceral fat is the ketogenic or keto diet.


Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



